ATLASATLAS fair value
ATLAS has no fair value for this stock today.
EUDA Health (EUDA)
EUDA Health stock price today, ATLAS forecast and fair value
Real Estate · Real Estate Services · NASDAQ
$14.48▲ +13.30%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
44%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on EUDA Health in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On EUDA Health
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives EUDA Health a 44% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $11.60 and $16.67; in 9 out of 10, between $8.41 and $23.00. Estimated annual volatility is 106%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $71.20
- 52-week low
- $5.26
- Revenue (12 months)
- $7.2M
- Revenue growth (YoY)
- +70.0%
- Gross margin
- 43.9%
- Operating margin
- -35.8%
- Net margin
- -40.6%
- Return on equity
- -211.4%
- Free cash flow (12 months)
- $-8.8M
- Beta
- 0.59
What this means
ATLAS does not publish a fair value for EUDA right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks EUDA has traded between $5.26 and $71.20. Today it is 79.7% below that high and 175% above its low.
On the business: revenue grew 70.0% year over year; net margin is 40.6%.
Its beta is 0.59: it tends to move less than the market.
About the company
EUDA Health Holdings Limited is a Singapore-based health technology and services company focused on non-invasive healthcare, preventive care, and wellness solutions across Southeast Asia and China.
Want to see everything about EUDA Health?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does EUDA Health do?
EUDA Health Holdings Limited is a Singapore-based health technology and services company focused on non-invasive healthcare, preventive care, and wellness solutions across Southeast Asia and China.
What is the chance EUDA goes up next month?
44%: somewhat worse than a coin flip. In half of the simulated outcomes, EUDA ends the month between $11.60 and $16.67.
How volatile is EUDA?
ATLAS estimates annual volatility at 106%. In a typical month, half of the outcomes end between $11.60 and $16.67.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer